None
Quote | Amneal Pharmaceuticals Inc. Class A (NYSE:AMRX)
Last: | $5.87 |
---|---|
Change Percent: | -0.17% |
Open: | $5.77 |
Close: | $5.87 |
High: | $5.95 |
Low: | $5.745 |
Volume: | 1,046,902 |
Last Trade Date Time: | 12/26/2023 03:00:00 am |
News | Amneal Pharmaceuticals Inc. Class A (NYSE:AMRX)
2024-07-01 10:22:31 ET More on Teva Pharmaceutical Teva Pharmaceutical: Buy This Bargain Before It's Gone Teva to pay $750M as part of tax deal with Israel Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcrip...
Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...
Message Board Posts | Amneal Pharmaceuticals Inc. Class A (NYSE:AMRX)
Subject | By | Source | When |
---|---|---|---|
MomentumIts gaining | dangerx | investorshub | 07/02/2023 10:42:27 PM |
best news of the day | ListenToMe | investorshub | 07/01/2023 1:35:40 PM |
$AMRX Price gaining | Elpapibh | investorshub | 06/29/2023 8:17:43 PM |
$AMRX MomentumIts now last trade up | ClayTrader | investorshub | 06/28/2023 2:43:21 PM |
$AMRX The gaining | ListenToMe | investorshub | 06/27/2023 2:57:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Amneal Pharmaceuticals Inc. Class A Website:
Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...
Builds on U.S. biosimilar portfolio of seven products with three commercial and four in pipeline 8 th biosimilar expands portfolio into allergy treatments, a new therapeutic area Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Companyȁ...
Fourth ESG Report Details Company’s Progress Towards Environmental Sustainability and Contributions Toward Building Healthier Communities as a Leading Provider of Accessible Medicines Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Companyȁ...